MMR-enzyme status (MMR-deficient/proficient: 10.1 ± 7.4 vs. 7.3 ± 5.5, p = 0.045), tumour localisation (right and left hemicolon: 9.6 ± 6.1 vs. 5.9 ± 4.7, p < 0.001) and nodal positivity (metastasised/non-metastasised node: 5.7 ± 3.4 vs. 4.4 ± 1.1 mm, p < 0.001) were associated with the lymph node size. Here, MRC1 is linked to neoplasm.